Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

Clinical Trial ID NCT00804154

PubWeight™ 7.28‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00804154

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994 9.54
2 The prevalence and severity of pain in cancer. Cancer 1982 2.07
3 The TRPA1 channel in migraine mechanism and treatment. Br J Pharmacol 2014 1.50
4 TRP channels and analgesia. Life Sci 2012 0.99
5 Transient receptor potential channels as targets for phytochemicals. ACS Chem Neurosci 2014 0.88
6 Preservation of acute pain and efferent functions following intrathecal resiniferatoxin-induced analgesia in rats. J Pain 2011 0.87
7 Intrathecal resiniferatoxin in a dog model: efficacy in bone cancer pain. Pain 2015 0.84
8 Pain of terminal cancer patients. Arch Intern Med 1978 0.78
9 Rational design and validation of a vanilloid-sensitive TRPV2 ion channel. Proc Natl Acad Sci U S A 2016 0.78
10 A Cytochrome P450-Mediated Intramolecular Carbon-Carbon Ring Closure in the Biosynthesis of Multidrug-Resistance-Reversing Lathyrane Diterpenoids. Chembiochem 2016 0.76
11 Current developments in intraspinal agents for cancer and noncancer pain. Curr Pain Headache Rep 2010 0.75
Next 100